Home › Funds › Royce & Associates › CDMO
Royce & Associates position in CDMO
AVID BIOSERVICES INC
Latest position (Q3 2024)789.23K sh
Reported value held$8.98M
Portfolio Weight0.08%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 227.60K | $4.91M | New |
| Q4 2021 | 188.70K | $5.51M | Reduce |
| Q1 2022 | 378.20K | $7.70M | Add |
| Q2 2022 | 329.70K | $5.03M | Reduce |
| Q3 2022 | 214.40K | $4.10M | Reduce |
| Q4 2022 | 256.00K | $3.52K | Add |
| Q1 2023 | 303.00K | $5.68K | Add |
| Q2 2023 | 303.00K | $4.23M | Hold |
| Q3 2023 | 278.00K | $2.62M | Reduce |
| Q4 2023 | 498.07K | $3.24M | Add |
| Q1 2024 | 638.30K | $4.28M | Add |
| Q2 2024 | 732.12K | $5.23M | Add |
| Q3 2024 | 789.23K | $8.98M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.